Role of KCTD proteins in striatal signaling
Role of KCTD proteins in striatal signaling
批准号:
10734241
负责人:
Brian S Muntean
金额:
$38.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
关键词:
AcuteBindingBiochemicalBiological AssayBrainCRISPR/Cas technologyCaringCellsClinicalCollectionComplexCorpus striatum structureCoupledCyclic AMPDataDeep Brain StimulationDevelopmentDisease ProgressionDyskinetic syndromeDystoniaEnvironmentEnzymesEtiologyEventFeedbackG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGeneticGenetic MarkersGoalsImageImpairmentInvestigationKnockout MiceLogisticsMolecularMotorMovement DisordersMutationNeuronsOpticsPathogenicityPathway interactionsPatient-Focused OutcomesPatientsPhysiologicalPhysiologyPlayPositioning AttributePotassium ChannelPrevalenceProcessProtein FamilyProteinsPublic HealthRegulationResearchRoleShapesSignal TransductionSignaling ProteinSliceTestingTherapeuticTissuesTransducersVariantWorkZincadenylyl cyclase type Vconditional knockoutdisease-causing mutationinsightmotor controlmouse modelnervous system disorderneuroregulationneurotransmissionoptical sensorpostsynapticpressurereceptorsensortargeted treatmenttherapeutically effectivetwo-photonzinc-binding protein
中文摘要
项目摘要
纹状体cAMP信号转导的改变有助于运动障碍的进展,
日益增加的流行率引起了严重的公共卫生问题。运动障碍的治疗选择
限制了部分由缺乏了解的纹状体神经元中的cAMP信号的分子控制。
尽管在解开cAMP途径方面已经取得了巨大的进展,但cAMP的复杂性仍然是一个未知的问题。
纹状体中的调节加上大量的具有关键作用的参与者尚未完全阐明
减缓了更有效的护理战略的进展。为了克服这一障碍,我们的长期目标是
更好地了解控制纹状体cAMP信号传导的机制和原理。拟议工作
着重于钾通道四聚化(KCTD)蛋白在纹状体信号调节中的作用
G蛋白偶联受体(GPCR)。最近发现KCTD蛋白参与GPCR信号转导
既直接通过与G蛋白结合,又间接通过影响锌转运蛋白的锌内流。
然而,KCTD对G蛋白信号传导的调节以及锌对纹状体信号传导的影响的细节,
才刚刚开始出现本提案的目的是阐明KCTD-锌-cAMP信号轴在
原生神经元环境。在目标1中,我们将使用生化分析来研究负反馈
压力,动态调整KCTD表达在纹状体,其次是光学分析,以研究如何
KCTD调节G蛋白与效应物的相互作用。目标2将利用生化分析和光学
传感器活神经元描绘精确的机制细节KCTD和锌对纹状体cAMP信号。
在目标3中,我们将讨论KCTD如何通过光学刺激来塑造天然生理信号询问
神经调节释放与跨完整回路的信号整合的同时双光子成像,
表达光学传感器的遗传定义的纹状体神经元。总的来说,拟议的研究预计将
重要的是,它将为KCTD-锌-cAMP提供基本的机制和生理学见解
对运动生理学关键信号过程的影响。
英文摘要
Project Summary
Alterations in striatal cAMP signal transduction contribute to the progression of movement disorders, whose
increasing prevalence present a significant public health concern. Therapeutic options for movement disorders
are limited in part by a deficient understanding of the molecular control of cAMP signaling in striatal neurons.
Although tremendous progress has been made in unraveling the cAMP pathway, complexity of cAMP
regulation in the striatum coupled with the large number of players with pivotal roles not yet fully elucidated has
slowed progress towards more effective care strategies. To overcome this barrier, our long-term goal is to
better understand the mechanisms and principles that control striatal cAMP signaling. The proposed work
focuses on the role of Potassium Channel Tetramerization (KCTD) proteins in modulation of striatal signaling
through G protein coupled receptors (GPCRs). KCTD proteins were recently implicated in GPCR signaling
both directly by engaging with G proteins and indirectly by influencing zinc influx through zinc transporters.
However, the details of KCTD regulation of G protein signaling and consequences of zinc on striatal signaling
are only beginning to emerge. The goal of this proposal is elucidation of the KCTD-Zinc-cAMP signaling axis in
the native neuronal environment. In Aim 1, we will use biochemical assays to study negative feedback
pressure that dynamically adjusts KCTD expression in the striatum followed by optical assays to study how
KCTD regulate interaction of G proteins with effectors. Aim 2 will utilize biochemical assays and optical
sensors in live neurons to delineate precise mechanistic details of KCTD and zinc on striatal cAMP signaling.
In Aim 3, we will address how KCTDs shape native physiological signal interrogation by optically stimulating
neuromodulatory release with concurrent 2-photon imaging of signal integration across intact circuits in
genetically defined striatal neurons expressing optical sensors. In total, the proposed research is expected to
be significant in that it will provide essential mechanistic and physiological insight into the KCTD-Zinc-cAMP
impact on signaling processes critical for motor physiology.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/ijms241814317
发表时间:
2023-09-20
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[]
通讯作者:
Role of RGS Proteins in Opioid Addiction
-
批准号:9306687
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2016
-
负责人:Brian S Muntean
-
依托单位:
Role of RGS Proteins in Opioid Addiction
-
批准号:9051491
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2016
-
负责人:Brian S Muntean
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: